MedTrace Logo

The Effect of "Eye Drop Guide" on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients

NCT01704248 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-10-11

No results posted yet for this study

Summary

To investigate if the Eye Drop Guide more effective than carefully instructed routine technique for chronic glaucoma patients to self-instill eye drops.

And what factors are associated with the failure of self-instillation eye drops with the Eye Drop Guide?

Conditions

  • Eye Drops Self-instillation

Interventions

DEVICE

Eye Drop Guide technique

1. Wash the hands. 2. Shake and then uncap the bottle. 3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand. 4. Use the lower lip of the cup to pull the lower lid down like what they normally do with the fingers. 5. Then place the upper lip down to cover the whole orbital rim area. 6. Tilt the head back if seated or standing. 7. Insert the bottle in the device all the way. Hold the bottle gently. 8. Look upward. 9. Squeeze the bottle one drop at a time until feel one drop instilled into the eye. 10. Close the eye 2-3 minutes. For the non-seeing eye (best-corrected visual acuity ≤ 20/400) the participants should insert the bottle in the device before cover the eye then proceed with head tilt and look upward.

BEHAVIORAL

Routine self-instillation technique

1. Wash the hands. 2. Shake and then uncap the bottle. 3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand. 4. Lie down or tilt the head back if seated or standing. 5. Using the other hand, pull the lower lid down. 6. Hold the bottle over the eye and look up. 7. Squeeze the bottle one drop at a time until feel one drop instilled into the eye. 8. Close the eye 2-3 minutes. For the participants using more than one medication after instilling one bottle the participants should wait 3-5 minutes between administering different medications in the same eye.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Darin Sakiyalak, MD · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-02-28
Completion
2013-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01704248 on ClinicalTrials.gov